An open, multicenter, non-comparative, phase IV trial of efficacy and safety of Ketek (telithromycin) 800mg.
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2009
At a glance
- Drugs Telithromycin (Primary)
- Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Sponsors Sanofi
- 15 Sep 2006 New trial record.